🔗 Permalink

Assignee profile:

APOGENIX AG

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2020-08-06

Patent Grants:

Last grant date:

2022-01-04

Top Inventors for applications by APOGENIX AG

These are the the leading inventors for applications assigned to APOGENIX AG:

Christian GIEFFERS 26 Dossenheim, Germany
Oliver HILL 25 Neckarsteinach, Germany
Meinolf THIEMANN 25 Schriesheim, Germany
Tim SCHNYDER 9 Igersheim, Germany

Harald Fricke 4 Mannheim, Germany
Christian MERZ 2 Neckarsteinach, Germany
Marcus BRANSCHÄDEL 2 Heidelberg, Germany
Marcus Branschädel 2 Heidelberg, Germany

Jaromir SYKORA 2 Heppenheim, Germany
Jaromir SYKORA 1 Heidelberg, Germany
Darren C. Phillips 1 Glenview, IL United States
Marcus Branschaedel 1 Heidelberg, Germany

Susan E. Lappe 1 Riverwoods, IL United States
Michaela Fontenay 1 Paris, France
Fritz G. Buchanan 1 Salem, WI United States
Marcus Branschaedel 1 Laupheim, Germany

Claudia KUNZ 1 Lustadt, Germany

Recent patent applications by APOGENIX AG

APOGENIX AG based in Heidelberg, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-08-06 ✅ Patent 11,214,605 granted on 2022-01-04

US20200247860A1

Chemistry; metallurgy

Light single-chain fusion polypeptides, encoding nucleic acid molecules and host cells

#2 | 2020-04-23 ✅ Patent 11,149,075 granted on 2021-10-19

US20200123223A1

Chemistry; metallurgy

Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) receptor agonist proteins

#3 | 2020-04-02 ✅ Patent 11,014,991 granted on 2021-05-25

US20200102397A1

Chemistry; metallurgy

Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody

#4 | 2019-06-20 ✅ Patent 10,519,208 granted on 2019-12-31

US20190185534A1

Chemistry; metallurgy

CD40L single-chain fusion polypeptides and encoding nucleic acids

#5 | 2019-01-24 ✅ Patent 10,640,543 granted on 2020-05-05

US20190023759A1

Chemistry; metallurgy

CD27 ligand (CD27L) single-chain fusion polypeptides

#6 | 2019-01-17 ✅ Patent 10,519,217 granted on 2019-12-31

US20190016780A1

Chemistry; metallurgy

CD27L collectin fusion proteins and encoding nucleic acids

#7 | 2018-09-06 ✅ Patent 10,683,332 granted on 2020-06-16

US20180251509A1

Chemistry; metallurgy

Single-chain light receptor agonist proteins

#8 | 2018-08-30 ✅ Patent 10,683,338 granted on 2020-06-16

US20180244753A1

Chemistry; metallurgy

Single-chain TL1A receptor agonist proteins

#9 | 2018-08-30 ✅ Patent 10,533,043 granted on 2020-01-14

US20180244752A1

Chemistry; metallurgy

Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) agonist proteins

#10 | 2018-08-30 ✅ Patent 10,844,108 granted on 2020-11-24

US20180244751A1

Chemistry; metallurgy

Single-chain CD27-receptor agonist proteins

#11 | 2018-08-23 ✅ Patent 10,870,688 granted on 2020-12-22

US20180237495A1

Chemistry; metallurgy

Single-chain CD137-receptor agonist proteins

#12 | 2018-07-26 ✅ Patent 10,428,154 granted on 2019-10-01

US20180208664A1

Chemistry; metallurgy

Monoclonal anti-CD95L antibody

#13 | 2018-07-05 ✅ Patent 10,370,441 granted on 2019-08-06

US20180186856A1

Chemistry; metallurgy

Nucleic acids encoding artificial signal peptides and methods of production thereof

#14 | 2018-03-08 ✅ Patent 10,793,616 granted on 2020-10-06

US20180066036A1

Chemistry; metallurgy

Single-chain CD40-receptor agonist proteins

#15 | 2017-11-02 ✅ Patent 10,118,953 granted on 2018-11-06

US20170313752A1

Chemistry; metallurgy

Glucocorticoid-induced tumor necrosis factor receptor ligand (GITRL) single-chain fusion polypeptides

#16 | 2017-03-23 ✅ Patent 10,000,550 granted on 2018-06-19

US20170081386A1

Chemistry; metallurgy

GITRL-collectin fusion proteins and encoding nucleic acids

#17 | 2017-02-16 ✅ Patent 10,266,600 granted on 2019-04-23

US20170044264A1

Chemistry; metallurgy

Diagnostic anti-CD95L antibody

#18 | 2016-12-15 ✅ Patent 9,908,928 granted on 2018-03-06

US20160362471A1

Chemistry; metallurgy

Artificial signal peptide

#19 | 2016-09-22 ✅ Patent 9,725,495 granted on 2017-08-08

US20160272695A1

Chemistry; metallurgy

CD27 single chain molecules and encoding nucleic acids

#20 | 2016-08-18 ✅ Patent 9,657,083 granted on 2017-05-23

US20160235815A1

Human necessities

Composition comprising a mixture of CD95-Fc isoforms

#21 | 2016-06-23 ✅ Patent 9,527,897 granted on 2016-12-27

US20160176941A1

Chemistry; metallurgy

CD40L collectin fusion proteins and encoding nucleic acid molecules

#22 | 2015-11-26 ✅ Patent 9,908,927 granted on 2018-03-06

US20150337027A1

Chemistry; metallurgy

Single-chain trail-receptor agonist proteins

#23 | 2015-06-18 ✅ Patent 9,434,783 granted on 2016-09-06

US20150166633A1

Chemistry; metallurgy

Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof

#24 | 2015-06-18 ✅ Patent 9,540,431 granted on 2017-01-10

US20150166632A1

Chemistry; metallurgy

Inhibitors of the CD95 signaling pathway for treatment of MDS

#25 | 2015-05-07 ✅ Patent 9,359,420 granted on 2016-06-07

US20150125419A1

Chemistry; metallurgy

Single chain trail fusion polypeptides and encoding nucleic acids

#26 | 2015-04-23 ✅ Patent 9,340,599 granted on 2016-05-17

US20150110734A1

Chemistry; metallurgy

Single chain CD40L fusion polypeptides

#27 | 2014-06-19 ✅ Patent 9,469,681 granted on 2016-10-18

US20140171622A1

Chemistry; metallurgy

Fusion proteins forming trimers

Also check out APOGENIX AG's (Heidelberg, Germany) applicant profile with 23 patent applications submitted.

AssigneeID:

369462 ⎘